Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

Objective: The outcome of the androgen-deprivation therapy (ADT) may be affected by metabolic diseases such as diabetes mellitus (DM) and dyslipidemia and/or by their treatments. We aimed to evaluate the prognostic impact of these disorders and corresponding medications in Japanese men treated with...

Full description

Bibliographic Details
Main Authors: Yu Hirata, Masaki Shiota, Takeshi Kobayashi, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Katsunori Tatsugami, Masatoshi Eto
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Prostate International
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888219300340